Skip to main content

Neuronetics, Inc.

STIM
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001227636

In the last 90 days, Neuronetics, Inc. insiders filed 2 open-market purchases and 0 sales; 86 institutions reported holding it in 13F filings for Q2 2026, worth $48.4M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Neuronetics, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of STIM: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders83277−4
Shares19.7M29.0K17.4M−2.27M (−11.5%)
Value$59.9M$88.0K$56.4M−$3.40M (−5.7%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held Neuronetics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to STIM in Q2 2022
InstitutionSharesValue% of portfolio
Ergoteles LLC125,100$402.0K0.01%
FNY Investment Advisers, LLC54,747$175.0K0.13%
Qube Research & Technologies Ltd22,685$73.0K0.00%
Susquehanna International Group, LLP17,007$55.0K0.00%
Y-Intercept (Hong Kong) Ltd10,901$35.0K0.00%
Spouting Rock Asset Management, LLC10,445$34.0K0.02%
Simplex Trading, LLC1,000$3.00K0.00%
Credit Suisse AG14$00.00%
Atwood & Palmer Inc100$00.00%

Sold out (13)

Institutions that held Neuronetics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (2)

Institutions that held Neuronetics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding STIM in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC24,991$76.0K
Amalgamated Financial Corp.4,043$12.0K